These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 21883200

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [Abstract] [Full Text] [Related]

  • 3. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ.
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [Abstract] [Full Text] [Related]

  • 4. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M.
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [Abstract] [Full Text] [Related]

  • 5. Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?
    Calhoun AH, Ford S.
    Postgrad Med; 2014 Mar; 126(2):86-90. PubMed ID: 24685971
    [Abstract] [Full Text] [Related]

  • 6. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
    Silberstein SD, Mannix LK, Goldstein J, Couch JR, Byrd SC, Ames MH, McDonald SA, Lener SE, Toso C.
    Neurology; 2008 Jul 08; 71(2):114-21. PubMed ID: 18606965
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes.
    Smith T, Blumenthal H, Diamond M, Mauskop A, Ames M, McDonald S, Lener S, Burch S.
    Headache; 2007 May 08; 47(5):683-92. PubMed ID: 17501849
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.
    Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R.
    Headache; 2005 May 08; 45(7):850-61. PubMed ID: 15985101
    [Abstract] [Full Text] [Related]

  • 11. Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine.
    Winner P, Cady RK, Ruoff GE, Frishberg BM, Alexander WJ, Zhang Y, Kori SH, Lener SE.
    Mayo Clin Proc; 2007 Jan 08; 82(1):61-8. PubMed ID: 17285787
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.
    Law S, Derry S, Moore RA.
    Cochrane Database Syst Rev; 2016 Apr 20; 4(4):CD008541. PubMed ID: 27096438
    [Abstract] [Full Text] [Related]

  • 15. Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.
    Rothrock JF, Cady RK, Aurora SK, Brandes JL, Myers JA, Fox AW, Farr SJ.
    Curr Med Res Opin; 2011 Nov 20; 27(11):2185-91. PubMed ID: 21942531
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A, Gennings C, Cady R.
    Headache; 2012 Apr 20; 52(4):636-47. PubMed ID: 22221151
    [Abstract] [Full Text] [Related]

  • 17. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr 20; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 18. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
    Cady RK, Aurora SK, Brandes JL, Rothrock JF, Myers JA, Fox AW, Farr SJ.
    Headache; 2011 Sep 20; 51(8):1202-11. PubMed ID: 21812775
    [Abstract] [Full Text] [Related]

  • 19. Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
    Cady RK, Diamond ML, Diamond MP, Ballard JE, Lener ME, Dorner DP, Derosier FJ, McDonald SA, White J, Runken MC.
    Headache; 2011 May 20; 51(5):664-73. PubMed ID: 21521204
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.